IDEXX Laboratories (BSP:I1DX34) Other Current Liabilities : R$579 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Other Current Liabilities?

IDEXX Laboratories's other current liabilities for the quarter that ended in Mar. 2024 was R$579 Mil.

IDEXX Laboratories's quarterly other current liabilities increased from Sep. 2023 (R$781 Mil) to Dec. 2023 (R$854 Mil) but then declined from Dec. 2023 (R$854 Mil) to Mar. 2024 (R$579 Mil).

IDEXX Laboratories's annual other current liabilities declined from Dec. 2021 (R$1,034 Mil) to Dec. 2022 (R$750 Mil) but then increased from Dec. 2022 (R$750 Mil) to Dec. 2023 (R$854 Mil).

IDEXX Laboratories Other Current Liabilities Historical Data

The historical data trend for IDEXX Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Other Current Liabilities Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

IDEXX Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

IDEXX Laboratories Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines